DSIP (Delta Sleep‑Inducing Peptide) is a research‑grade neuropeptide investigated in controlled laboratory environments for its potential roles in sleep regulation, stress‑response pathways, and neuroendocrine signaling. Current scientific interest focuses on DSIP’s interaction with central nervous system peptides, modulation of circadian‑related biochemical markers, and its influence on hypothalamic activity under experimental conditions.

Within the Canatide research catalog, DSIP is provided strictly as a high‑purity peptide for in‑vitro and in‑vivo laboratory studies. It is intended for mechanistic exploration, assay development, and model‑based experimentation involving peptide stability, receptor affinity, and neurochemical pathway mapping.

This material is not intended for human or veterinary use.